Hims & Hers Health Inc. buy Needham & Company LLC
Start price
25.02.25
/
50%
€38.14
Target price
25.02.26
€58.08
Performance (%)
26.01%
Price
13.06.25
€48.06
Summary
This prediction is currently active. The prediction currently has a performance of 26.01%. This prediction currently runs until 25.02.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hims & Hers Health Inc. | -2.850% | -2.850% |
| iShares Core DAX® | -3.750% | -0.949% |
| iShares Nasdaq 100 | -1.884% | -1.051% |
| iShares Nikkei 225® | -1.249% | -2.238% |
| iShares S&P 500 | -1.669% | -1.463% |
Comments by Needham___Company_LL for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Needham & Company LLC from $31.00 to $61.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Stopped prediction by Needham___Company_LL for Hims & Hers Health Inc.
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€48.75
04.06.25
04.06.25
€57.08
04.06.26
04.06.26
-1.42%
13.06.25
13.06.25
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€34.47
06.05.25
06.05.25
€54.01
06.05.26
06.05.26
39.43%
13.06.25
13.06.25
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€26.43
06.01.25
06.01.25
€29.74
06.01.26
06.01.26
81.84%
13.06.25
13.06.25
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€15.69
22.08.24
22.08.24
€21.54
22.08.25
22.08.25
206.31%
13.06.25
13.06.25